Cargando…

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors

While the role of prostaglandin E2 (PGE2) in promoting malignant progression is well established, how to optimally block the activity of PGE2 signaling remains to be demonstrated. Clinical trials with prostaglandin pathway targeted agents have shown activity but without sufficient significance or do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francica, Brian J., Holtz, Anja, Lopez, Justine, Freund, David, Chen, Austin, Wang, Dingzhi, Powell, David, Kipper, Franciele, Panigrahy, Dipak, Dubois, Raymond N., Whiting, Chan C., Prasit, Peppi, Dubensky, Thomas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408683/ https://www.ncbi.nlm.nih.gov/pubmed/37559947 http://dx.doi.org/10.1158/2767-9764.CRC-23-0249

Ejemplares similares

Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E(2) Activation in Human Podocytes
por: Mangelsen, Eva, et al.
Publicado: (2020)

Regulation of prostaglandin EP(1) and EP(4) receptor signaling by carrier-mediated ligand reuptake
por: Chi, Yuling, et al.
Publicado: (2014)

Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients
por: Minatani, Atsushi, et al.
Publicado: (2016)

Prostaglandin E(2) Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP(2) and EP(4)
por: Torres-Atencio, Ivonne, et al.
Publicado: (2014)

Cloning and expression of the rabbit prostaglandin EP2 receptor
por: Guan, Youfei, et al.
Publicado: (2002)

Role of EP(2) and EP(4) receptors in airway microvascular leak induced by prostaglandin E(2)
por: Jones, Victoria C, et al.
Publicado: (2016)

Inhibitory effects of prostaglandin EP(4 )receptors on human eosinophils
por: Luschnig-Schratl, Petra, et al.
Publicado: (2009)

Prostaglandin E2 promotes human CD34(+) cells homing through EP2 and EP4 in vitro
por: Wang, Yaqun, et al.
Publicado: (2017)

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020)

Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer
por: Hiken, Jeffrey F., et al.
Publicado: (2016)

Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis
por: Klasen, Charlotte, et al.
Publicado: (2019)

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
por: Carlson, Noel G, et al.
Publicado: (2009)

Opposing effects of prostaglandin E(2) receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
por: Carboneau, Bethany A., et al.
Publicado: (2017)

Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules
por: Vleeshouwers, Ward, et al.
Publicado: (2021)

The role of the EP receptors for prostaglandin E(2) in skin and skin cancer
por: Rundhaug, J. E., et al.
Publicado: (2011)

Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
por: Chang, Jian, et al.
Publicado: (2015)

Gene expression of prostaglandin EP4 receptor in three canine carcinomas
por: Musser, Margaret L., et al.
Publicado: (2020)

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)

Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)

Ca(2+) signals evoked by histamine H(1) receptors are attenuated by activation of prostaglandin EP(2) and EP(4) receptors in human aortic smooth muscle cells
por: Pantazaka, Evangelia, et al.
Publicado: (2013)

Blockade of EP4 by ASP7657 Modulates Myeloid Cell Differentiation In Vivo and Enhances the Antitumor Effect of Radiotherapy
por: Nishibata, Toshihide, et al.
Publicado: (2023)

Prostaglandin E(2) promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation
por: Mo, Chenglin, et al.
Publicado: (2015)

T cell–intrinsic prostaglandin E(2)-EP2/EP4 signaling is critical in pathogenic T(H)17 cell–driven inflammation
por: Lee, Jinju, et al.
Publicado: (2019)

Prostaglandin receptors EP and FP are regulated by estradiol and progesterone in the uterus of ovariectomized rats
por: Blesson, Chellakkan S, et al.
Publicado: (2012)

Role of the Prostaglandin E(2) EP1 Receptor in Traumatic Brain Injury
por: Glushakov, Alexander V., et al.
Publicado: (2014)

Heterodimerization of the prostaglandin E2 receptor EP2 and the calcitonin receptor CTR
por: Matsubara, Shin, et al.
Publicado: (2017)

Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation
por: Kirkby Shaw, Kristin, et al.
Publicado: (2015)

Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear
por: Hori, Ryusuke, et al.
Publicado: (2010)

Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling
por: Boniface, Katia, et al.
Publicado: (2009)

Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice
por: Hosono, Kanako, et al.
Publicado: (2016)

Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells
por: Mançanares, Ana Carolina Furlanetto, et al.
Publicado: (2020)

Coordinated surface activities in Variovorax paradoxus EPS
por: Jamieson, W David, et al.
Publicado: (2009)

The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma
por: Hosono, Hideki, et al.
Publicado: (2020)

A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG(2a)-f) Exerts Antitumor Activity in Xenograft Model
por: Asano, Teizo, et al.
Publicado: (2022)

Prostacyclin-IP signaling and prostaglandin E(2)-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis
por: Honda, Tetsuya, et al.
Publicado: (2006)

Sensitization of TRPV1 by EP(1 )and IP reveals peripheral nociceptive mechanism of prostaglandins
por: Moriyama, Tomoko, et al.
Publicado: (2005)

Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1
por: Nagamachi, Miyako, et al.
Publicado: (2007)

A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
por: Philipose, Sonia, et al.
Publicado: (2010)

Prostaglandin E(2 )acts via the EP(4 )receptor to inhibit platelet aggregation
por: Philipose, Sonia, et al.
Publicado: (2009)

Upregulation of Prostaglandin Receptor EP(1) Expression Involves Its Association with Cyclooxygenase-2
por: Sood, Rapita, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ub9739gkc5sdhp7n76oigj5eke